Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 281

Similar articles for PubMed (Select 16470120)

1.

Acute renal failure in hospitalized patients with HIV: risk factors and impact on in-hospital mortality.

Wyatt CM, Arons RR, Klotman PE, Klotman ME.

AIDS. 2006 Feb 28;20(4):561-5.

PMID:
16470120
2.

Risk of diabetes in HIV infected veterans pre- and post-HAART and the role of HCV coinfection.

Butt AA, Fultz SL, Kwoh CK, Kelley D, Skanderson M, Justice AC.

Hepatology. 2004 Jul;40(1):115-9.

PMID:
15239093
3.

Hepatitis C coinfection increases the risk of fulminant hepatic failure in patients with HIV in the HAART era.

Kramer JR, Giordano TP, Souchek J, El-Serag HB.

J Hepatol. 2005 Mar;42(3):309-14.

PMID:
15710213
4.
5.

Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.

Grau I, Pallares R, Tubau F, Schulze MH, Llopis F, Podzamczer D, Liñares J, Gudiol F; Spanish Pneumococcal Infection Study Network (G03/103).

Arch Intern Med. 2005 Jul 11;165(13):1533-40.

PMID:
16009870
6.

Outcome of HIV-associated Pneumocystis pneumonia in hospitalized patients from 2000 through 2003.

Radhi S, Alexander T, Ukwu M, Saleh S, Morris A.

BMC Infect Dis. 2008 Sep 16;8:118. doi: 10.1186/1471-2334-8-118.

7.

Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit.

Casalino E, Wolff M, Ravaud P, Choquet C, Bruneel F, Regnier B.

AIDS. 2004 Jul 2;18(10):1429-33.

PMID:
15199319
8.

HIV-related lung cancer in the era of highly active antiretroviral therapy.

Bower M, Powles T, Nelson M, Shah P, Cox S, Mandelia S, Gazzard B.

AIDS. 2003 Feb 14;17(3):371-5.

PMID:
12556691
9.

Characteristics and outcomes of HIV-infected patients in the ICU: impact of the highly active antiretroviral treatment era.

Vincent B, Timsit JF, Auburtin M, Schortgen F, Bouadma L, Wolff M, Regnier B.

Intensive Care Med. 2004 May;30(5):859-66. Epub 2004 Feb 6.

PMID:
14767592
10.

Malignancies in HIV: pre- and post-highly active antiretroviral therapy.

Nutankalva L, Wutoh AK, McNeil J, Frederick WR, Reddy RB, Daftary M, Gentles A, Addae-Afoakwa K.

J Natl Med Assoc. 2008 Jul;100(7):817-20.

PMID:
18672558
11.

Acute kidney injury in hospitalized HIV-infected patients: a cohort analysis.

Lopes JA, Melo MJ, Viegas A, Raimundo M, Câmara I, Antunes F, Gomes da Costa A.

Nephrol Dial Transplant. 2011 Dec;26(12):3888-94. doi: 10.1093/ndt/gfr192. Epub 2011 May 4.

12.

Trends of mortality and causes of death among HIV-infected patients in Taiwan, 1984-2005.

Yang CH, Huang YF, Hsiao CF, Yeh YL, Liou HR, Hung CC, Yang SY.

HIV Med. 2008 Aug;9(7):535-43. doi: 10.1111/j.1468-1293.2008.00600.x. Epub 2008 Jun 28.

PMID:
18554309
13.
14.

Progression of HIV infection in the post-HAART era among a cohort of HIV+ Greek haemophilia patients.

Katsarou O, Touloumi G, Antoniou A, Kouramba A, Hatzakis A, Karafoulidou A.

Haemophilia. 2005 Jul;11(4):360-5.

PMID:
16011588
15.

Is the increased risk of liver enzyme elevation in patients co-infected with HIV and hepatitis virus greater in those taking antiretroviral therapy?

Cicconi P, Cozzi-Lepri A, Phillips A, Puoti M, Antonucci G, Manconi PE, Tositti G, Colangeli V, Lichtner M, Monforte Ad; ICoNA Study Group.

AIDS. 2007 Mar 12;21(5):599-606.

PMID:
17314522
16.

Low rates of antiretroviral therapy among HIV-infected patients with chronic kidney disease.

Choi AI, Rodriguez RA, Bacchetti P, Volberding PA, Havlir D, Bertenthal D, Bostrom A, O'Hare AM.

Clin Infect Dis. 2007 Dec 15;45(12):1633-9. doi: 10.1086/523729.

17.

HIV care and the incidence of acute renal failure.

Roe J, Campbell LJ, Ibrahim F, Hendry BM, Post FA.

Clin Infect Dis. 2008 Jul 15;47(2):242-9. doi: 10.1086/589296.

18.

Factors associated with chronic renal failure in HIV-infected ambulatory patients.

Krawczyk CS, Holmberg SD, Moorman AC, Gardner LI, McGwin G Jr; HIV Outpatient Study Group.

AIDS. 2004 Nov 5;18(16):2171-8.

PMID:
15577650
19.

Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras.

Crum NF, Riffenburgh RH, Wegner S, Agan BK, Tasker SA, Spooner KM, Armstrong AW, Fraser S, Wallace MR; Triservice AIDS Clinical Consortium.

J Acquir Immune Defic Syndr. 2006 Feb 1;41(2):194-200.

PMID:
16394852
20.

Impact of hepatitis B virus co-infection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: a nationwide cohort study.

Omland LH, Weis N, Skinhøj P, Laursen A, Christensen PB, Nielsen HI, Møller A, Engsig F, Sørensen HT, Obel N.

HIV Med. 2008 May;9(5):300-6. doi: 10.1111/j.1468-1293.2008.00564.x.

PMID:
18400077
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk